BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 18797146)

  • 1. Liposomal amphotericin B for a case of intractable cryptococcal meningoencephalitis and immune reconstitution syndrome.
    Sasakawa A; Yamamoto Y; Yajima K; Sakai M; Uehira T; Shirasaka T; Makie T
    J Med Invest; 2008 Aug; 55(3-4):292-6. PubMed ID: 18797146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.
    Leenders AC; Reiss P; Portegies P; Clezy K; Hop WC; Hoy J; Borleffs JC; Allworth T; Kauffmann RH; Jones P; Kroon FP; Verbrugh HA; de Marie S
    AIDS; 1997 Oct; 11(12):1463-71. PubMed ID: 9342068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
    van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
    N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.
    Lawrence DS; Youssouf N; Molloy SF; Alanio A; Alufandika M; Boulware DR; Boyer-Chammard T; Chen T; Dromer F; Hlupeni A; Hope W; Hosseinipour MC; Kanyama C; Lortholary O; Loyse A; Meya DB; Mosepele M; Muzoora C; Mwandumba HC; Ndhlovu CE; Niessen L; Schutz C; Stott KE; Wang D; Lalloo DG; Meintjes G; Jaffar S; Harrison TS; Jarvis JN
    Trials; 2018 Nov; 19(1):649. PubMed ID: 30470259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
    Sloan D; Dlamini S; Paul N; Dedicoat M
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study.
    Sungkanuparph S; Filler SG; Chetchotisakd P; Pappas PG; Nolen TL; Manosuthi W; Anekthananon T; Morris MI; Supparatpinyo K; Kopetskie H; Kendrick AS; Johnson PC; Sobel JD; Larsen RA
    Clin Infect Dis; 2009 Sep; 49(6):931-4. PubMed ID: 19681708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective study on the efficacy and safety of amphotericin B in a lipid emulsion for the treatment of cryptococcal meningitis in AIDS patients.
    Torre D; Banfi G; Tambini R; Speranza F; Zeroli C; Martegani R; Airoldi M; Fiori G
    J Infect; 1998 Jul; 37(1):36-8. PubMed ID: 9733375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging of HIV-associated cryptococcal meningitis: comparison of magnetic resonance imaging findings in patients with and without immune reconstitution.
    Katchanov J; Branding G; Jefferys L; Arastéh K; Stocker H; Siebert E
    Int J STD AIDS; 2016 Feb; 27(2):110-7. PubMed ID: 25693580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
    Jarvis JN; Lawrence DS; Meya DB; Kagimu E; Kasibante J; Mpoza E; Rutakingirwa MK; Ssebambulidde K; Tugume L; Rhein J; Boulware DR; Mwandumba HC; Moyo M; Mzinganjira H; Kanyama C; Hosseinipour MC; Chawinga C; Meintjes G; Schutz C; Comins K; Singh A; Muzoora C; Jjunju S; Nuwagira E; Mosepele M; Leeme T; Siamisang K; Ndhlovu CE; Hlupeni A; Mutata C; van Widenfelt E; Chen T; Wang D; Hope W; Boyer-Chammard T; Loyse A; Molloy SF; Youssouf N; Lortholary O; Lalloo DG; Jaffar S; Harrison TS;
    N Engl J Med; 2022 Mar; 386(12):1109-1120. PubMed ID: 35320642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial.
    Bicanic T; Wood R; Meintjes G; Rebe K; Brouwer A; Loyse A; Bekker LG; Jaffar S; Harrison T
    Clin Infect Dis; 2008 Jul; 47(1):123-30. PubMed ID: 18505387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of antifungal drug levels in cerebrospinal fluid for cryptococcal meningoencephalitis.
    Shoji H; Takuma T; Ohbayashi H; Yoshida K; Yamamoto T; Niki Y
    J Infect Chemother; 2012 Oct; 18(5):775-9. PubMed ID: 22318291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety.
    Hamill RJ; Sobel JD; El-Sadr W; Johnson PC; Graybill JR; Javaly K; Barker DE
    Clin Infect Dis; 2010 Jul; 51(2):225-32. PubMed ID: 20536366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
    Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
    Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptococcal meningitis with atypical paradoxical inflammatory reactions after antifungal treatment in acquired immune deficiency syndrome: A case report.
    Samukawa S; Yoshimi R; Kojitani N; Uzawa Y; Takase-Minegishi K; Kirino Y; Soejima Y; Kato H; Nakajima H
    J Infect Chemother; 2023 Mar; 29(3):347-352. PubMed ID: 36384196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis.
    Jackson AT; Nussbaum JC; Phulusa J; Namarika D; Chikasema M; Kanyemba C; Jarvis JN; Jaffar S; Hosseinipour MC; van der Horst C; Harrison TS
    AIDS; 2012 Jul; 26(11):1363-70. PubMed ID: 22526517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal cryptococcal meningitis in an AIDS patient complicated with immune reconstitution syndrome refractory to prolonged amphotericin B treatment.
    Bandaranayake TD; Ogbuagu OE; Mahajan A; Vortmeyer AO; Villanueva MS
    Int J STD AIDS; 2018 Oct; 29(12):1250-1254. PubMed ID: 29749873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study.
    Xu L; Liu J; Zhang Q; Li M; Liao J; Kuang W; Zhu C; Yi H; Peng F
    Neurol Res; 2018 May; 40(5):398-404. PubMed ID: 29560802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal treatment for cryptococcal meningitis.
    Powderly WG
    Intern Med J; 2006 Jul; 36(7):404-5. PubMed ID: 16780444
    [No Abstract]   [Full Text] [Related]  

  • 19. Liposomal amphotericin B (Fungisome) for the treatment of cryptococcal meningitis in HIV/AIDS patients in India: a multicentric, randomized controlled trial.
    Jadhav MP; Bamba A; Shinde VM; Gogtay N; Kshirsagar NA; Bichile LS; Mathai D; Sharma A; Varma S; Digumarathi R
    J Postgrad Med; 2010; 56(2):71-5. PubMed ID: 20622383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical problems in medical mycology: problem number 41].
    Negroni R; Arechavala A; Maiolo E; Bianchi M; Santiso G; Lehmann E
    Rev Iberoam Micol; 2011; 28(1):53-5. PubMed ID: 21167296
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.